Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$43.48 -0.49 (-1.11%)
As of: Sep 30, 2026 · 11:39 AM EDT

Supernus Pharmaceuticals (SUPN) Receivables - Other (2024 - 2026)

Updated

Supernus Pharmaceuticals (SUPN) reported Receivables - Other of $4.3 million for Q2 2026, down 20.4% from $5.4 million a year earlier but up 126.3% from the prior quarter.

Analysis

Supernus Pharmaceuticals (SUPN) Receivables - Other (2024 - 2026) Analysis & Trends

At the end of FY2025, Supernus Pharmaceuticals posted Receivables - Other of $1.8 million, down 55.0% from FY2024.

  • By year, Receivables - Other came in at $4 million in FY2024.
  • Five-year quarterly Receivables - Other spans a low of $1.8 million in Q4 2025 and a high of $6.3 million in Q3 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.9 million (Q1 2026), $1.8 million (Q4 2025) and $6.3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Supernus Pharmaceuticals 2.59 Bn 1.25 Bn 185.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.30 Mn
Mar 31, 2026 1.90 Mn
Dec 31, 2025 1.80 Mn
Sep 30, 2025 6.30 Mn
Jun 30, 2025 5.40 Mn
Dec 31, 2024 4.00 Mn
API Access

Supernus Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=SUPN&period=max&api_key=YOUR_API_KEY